Growth Metrics

Eli Lilly (LLY) Exchange Rate Effect (2016 - 2026)

Eli Lilly filings provide 18 years of Exchange Rate Effect readings, the most recent being $67.0 million for Q1 2026.

  • On a quarterly basis, Exchange Rate Effect fell 49.24% to $67.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $307.0 million, a 337.07% increase, with the full-year FY2025 number at $372.0 million, up 225.25% from a year prior.
  • Exchange Rate Effect hit $67.0 million in Q1 2026 for Eli Lilly, up from -$67.1 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $275.4 million in Q2 2025 to a low of -$428.8 million in Q4 2024.
  • Median Exchange Rate Effect over the past 5 years was $9.2 million (2023), compared with a mean of $8.4 million.
  • Biggest five-year swings in Exchange Rate Effect: crashed 906.98% in 2022 and later skyrocketed 4181.13% in 2024.
  • Eli Lilly's Exchange Rate Effect stood at -$128.2 million in 2022, then skyrocketed by 201.17% to $129.7 million in 2023, then plummeted by 430.61% to -$428.8 million in 2024, then soared by 84.35% to -$67.1 million in 2025, then skyrocketed by 199.85% to $67.0 million in 2026.
  • The last three reported values for Exchange Rate Effect were $67.0 million (Q1 2026), -$67.1 million (Q4 2025), and $31.7 million (Q3 2025) per Business Quant data.